Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1999-03-22
2000-11-21
Krass, Frederick
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514535, 514543, 424450, 600562, A61K 31235, A61K 3124, A61K 3119
Patent
active
061504076
ABSTRACT:
The present invention relates to methods for effectively inhibiting unwanted angiogenesis. More particularly, this invention relates to methods of treating diseases that show unwanted angiogenesis and to delivering anti-angiogenic activity to a mammal. In other aspects this invention relates to methods of reducing the level of tumor necrosis factor .alpha..
REFERENCES:
patent: 4994443 (1991-02-01), Folkman et al.
patent: 5001116 (1991-03-01), Folkman et al.
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5736576 (1998-04-01), Kun et al.
patent: 6017958 (2000-01-01), Kun et al.
Borrows, E.T., "The synthesis of thyroxine and related substances. Part I. The preparation of tyrosine and some of its derivatives, and a new route to thyroxine", J. Chem. Soc., S185-190, (1949).
Masuda, et al., "Thyroxine related compunds", Takeda Kenkyusho Ho, 30(3):466-474 (1971).
Tripp, Spencer L., et al., "Synthesis of methylene-and carbonyl-bridged analogs of iodothyronines and iodothyroacetic acids", J. Med. Chem., 16(1):60-64 (1973).
Auerbach, et al., "A simple procedure for the long-term cultivation of chicken embryos", Dev. Biol., 41:391-394 (1974).
Taylor, et al., "Protamine is an inhibitor of angiogenesis", Nature, 297:307-312 (1982).
Folkman, et al., "Angiogenesis inhibition and tumor regresion caused by heparin or a heparin fragment in the presence of cortisone", Science, 221:719-725 (1983).
Tracey, et al., "Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia", Nature, 330:662-664 (1987).
Maragoudakis, et al., "Antiangiogenic action of heparin plus cortisone is associated with decreased collagenous protein synthesis in the chick chorioallantoic membrane system", J. Pharm. Exp. Ther., 251:679-682 (1989).
Silva, et al., "Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-.alpha. in experimental gram-negative shock", J. Infect. Dis., 162:421-427 (1990).
Langer, Robert, ew methods of drug delivery, Science, 249:1527-1533 (1990).
Williams, et al., "Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis", Proc. Natl. Acad. Sci. USA, 89:9784-9788 (1992).
Waleh, et al., "Selective down-regulation of integrin receptors in spheroids of squamous cell carcinoma", Cancer Res., 54:838-843 (1994).
Jain, et al., "Quantitative angiogenesis assays: progress and problems", Nat. Med., 3(11):1203-1208 (1997).
Lin, et al., "Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth", J. Clin. Invest., 100(8):2072-2078 (1997).
Mendeleyev, Jerome, et al., "Structural specificity and tumoricidal action of methyl-3,5-diiodo-4-(4'-methoxyphenoxy) benzoate (DIME)", Int. J. Oncol., 10(4):689-695 (1997).
Kun, Ernest, et al., "Molecular pharmacology of methyl-3,5-diiodo-4 (4-3 methoxyphenoxy) benzoate (DIME) and its non-hydrolyzible ethanone analog (DIPE)* (Review)", Int. J. Mol. Med., 2(5):585-590 (Nov. 11, 1998).
Chen, Xiaoying, et al., "Oncocidin A1: A novel tublin-binding drug with antitumor activity against human breast and ovarian carcinoma xenografts in nude mide", Biochem. Pharmacol., 56(5):623-633 (Sep. 01, 1998).
Hiebert Charles
Laderoute Keith R.
Tuse Daniel
Waleh Nahid
Krass Frederick
Large Scale Biology Corporation
SRI - International
LandOfFree
Methods for inhibiting angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for inhibiting angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for inhibiting angiogenesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1257852